Patent · US Active

Compounds and uses thereof in modulating amyloid β

US8017629B2 · kind B2 · utility

14Cited by
54References
29Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 23, 2010
Grant dateSep 13, 2011
Priority date
Expiry dateAug 23, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/14
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Novel compounds, compositions, and kits are provided. Methods of modulating Aβ levels, and methods of treating a disease associated with aberrant Aβ levels are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.